• It was a solid day at the end of what has been a very solid week on Wall Street.
  • The S&P 500 and Dow posted five days in the green in a row.
  • The Nasdaq 100 and S&P 500 both hit fresh all-time highs on Friday.

A solid day at the end of what has been a very solid week on Wall Street; the S&P 500 closed 0.41% higher on the day, ending the week with gains of 4.65%, the Dow closed the day with gains of 0.3%, ending the week with gains of 3.89% and the Nasdaq Composite closed the session up 0.53%, ending the week with gains of 6.01%. For the S&P 500 and Dow, that meant five straight sessions in the green, the longest winning streak for the indices since August 2020.

Elsewhere, the small-cap Russell 2000 also had a good day, finishing the session with gains on the day of 1.3% and on the week of 7.7%, the index’s best weekly gain since the start of June 2020. Moreover, five days of straight gains handed the index it’s longest winning streak since May 2020.

It’s been a stunning turnaround for US stock markets this week; US equities ended last week on a nervous note amid concerns regarding the surge in speculative retail investor activity in popular hedge fund shorted stocks such as GameStop and AMC. On the week, the S&P 500 lost more than 3.5%. But the major US equity indices have all more than made up for last week, with the S&P 500, the Nasdaq 100 and Russell 2000 all surging back to all-time highs. The Dow didn’t quite make it back to record levels but is only missed out by about 0.1%.

This week’s gains soothed investors' nerves about the potential for future volatility; the CBOE volatility index dropped again on Friday to just under 21.00, its lowest closing level since the start of December and the largest weekly drop for the index since the start of November.

Drivers this week

The fundamental backdrop became increasingly bullish as the week progressed; firstly, the US Congress is moving towards more fiscal stimulus. The Democrats will attempt to pass the new stimulus bill via a process called budget reconciliation and the votes to start this process have already passed the House and Senate. Markets do not expect US President Joe Biden to get his full $1.9T package through Congress, but they do expect something big (likely in the trillions of dollars). This will, of course, boost near-term economic activity, boosting company earnings and is likely also to boost inflation, meaning companies raising prices, which also leads to higher earnings (in nominal terms at least, which in fairness is what stocks are priced in).

For the most part, US data this week was strong and this seemed to also help stocks, though the US dollar (which could, but didn’t seem to, present an impediment to further stock gains). But that changed on Friday; the January NFP report underwhelmed, and the US dollar fell (which in itself is likely to be a US stock market positive). The data underscored the need for further fiscal stimulus to Congress, something President Biden was keen to emphasise, and is being seen as making a bigger package more likely. (hence why stocks loved it so much today).  

Earnings have been another tailwind; Q4 earnings reports were expected to show a drop in profits but, net-net, US companies are on course to post earnings growth on the quarter, Reuters reported earlier in the week citing Refinitiv data. Tech giants Amazon, Google, Apple, Microsoft and Facebook all beat earnings expectations; “big business in America has learned how to manage through the COVID crisis” said Cherry Lane Investments partner Rick Meckler. “It's the small companies, the family-owned businesses, restaurants and some specific industries that have been badly hurt.”

News on the pandemic front has also for the most part been positive; Johnson & Johnson results were good and the company is applying for emergency use authorisation in the US. The Sputnik V vaccine was shown to be highly effective. Studies on the efficacy of the AstraZeneca vaccine show it significantly reduces transmission whilst also preventing patients from serious disease. More specifically to the US, the pandemic appears to be slowing down, whilst the country’s vaccination drive has been amping up.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Feed news Join Telegram

Recommended content

Recommended content

Editors’ Picks

EUR/USD holds above 1.0700 after US inflation data

EUR/USD holds above 1.0700 after US inflation data

EUR/USD stays in the lower half of its daily range but continues to trade above 1.0700 in the early American session on Friday. The data from the US showed that the annual Core PCE Price Index declined to 4.9% in April as expected, making it difficult for the dollar to gather strength.


GBP/USD trades above 1.2600 as dollar struggles to find demand

GBP/USD trades above 1.2600 as dollar struggles to find demand

GBP/USD clings to daily gains above 1.2600 and remains on track to end the week in positive territory. The greenback struggles to attract investors after the data from the US showed that PCE inflation softened in April. 


Gold pulls away from daily highs, holds above $1,850

Gold pulls away from daily highs, holds above $1,850

Gold has lost its traction in the second half of the day on Friday and declined toward the $1,850 area. The benchmark 10-year US Treasury bond yield staged a modest rebound on the US PCE inflation data, not allowing XAU/USD to preserve its bullish momentum.

Gold News

Terra’s LUNA 2.0 support expands with Binance and Kraken welcoming the airdrop, here’s how you need to prepare

Terra’s LUNA 2.0 support expands with Binance and Kraken welcoming the airdrop, here’s how you need to prepare

Terra’s LUNA fork proposal has passed with 65.5% votes, Revival Plan 2 in action without algorithmic stablecoin UST. LUNA price could wipe out losses incurred by holders in the colossal crash of LUNC and UST. 

Read more

FXStreet Premium users exceed expectations

FXStreet Premium users exceed expectations

Tap into our 20 years Forex trading experience and get ahead of the markets. Maximize our actionable content, be part of our community, and chat with our experts. Join FXStreet Premium today!